» Articles » PMID: 33915767

Effectiveness of Antipsychotics in Reducing Suicidal Ideation: Possible Physiologic Mechanisms

Overview
Specialty Health Services
Date 2021 Apr 30
PMID 33915767
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

: The aim of this study is to evaluate whether any specific antipsychotic regimen or dosage is effective in managing suicidal ideation in schizophrenia. Four comparisons were conducted between: (1) clozapine and other antipsychotics; (2) long-acting injectable and oral antipsychotics; (3) atypical and typical antipsychotics; (4) antipsychotics augmented with antidepressants and antipsychotic treatment without antidepressant augmentation. : We recruited 103 participants diagnosed with schizophrenia spectrum disorders. Participants were followed for at least six months. The Beck Scale for Suicidal Ideation (BSS) was used to assess the severity of suicidal ideation at each visit. We performed a multiple linear regression model controlling for BSS score at study entry and other confounding variables to predict the change in the BSS scores between two visits. : Overall, there were 28 subjects treated with clozapine (27.2%), and 21 subjects with depot antipsychotics (20.4%). In our sample, 30 subjects experienced some suicidal ideation at study entry. When considering the entire sample, there was a statistically significant decrease in suicidal ideation severity in the follow-up visit compared to the study entry visit ( = 0.043). : To conclude, our preliminary analysis implies that antipsychotics are effective in controlling suicidal ideation in schizophrenia patients, but no difference was found among alternative antipsychotics' classes or dosages.

Citing Articles

Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.

Stromme M, Thue Augustsson M, Bartz-Johannessen C, Stautland A, Mykletun A, Kroken R Psychol Med. 2024; :1-9.

PMID: 39651581 PMC: 11780172. DOI: 10.1017/S0033291724002873.


Incidence and trend of cardiac events among children and young adults exposed to psychopharmacological treatment (2006-2018): A nationwide register-based study.

Elmowafi H, Kindblom J, Halldner L, Gyllenberg D, Naumburg E Br J Clin Pharmacol. 2024; 91(3):817-828.

PMID: 39448545 PMC: 11862795. DOI: 10.1111/bcp.16321.


Psychotropic Medications Promote Time-Dependent Reduction of Suicidal Ideation in Mood Disorder: A Prospective Cohort Study.

Yang J, Park C, Rhee S, Kang D, Kim M, Lee H J Korean Med Sci. 2024; 39(31):e226.

PMID: 39137811 PMC: 11319105. DOI: 10.3346/jkms.2024.39.e226.


Long-term effects of antipsychotics on mortality in patients with schizophrenia: a systematic review and meta-analysis.

Jia N, Li Z, Li X, Jin M, Liu Y, Cui X Braz J Psychiatry. 2023; 44(6):664-673.

PMID: 36709510 PMC: 9851750. DOI: 10.47626/1516-4446-2021-2306.


Factorial Model of Obese Adolescents: The Role of Body Image Concerns and Selective Depersonalization-A Pilot Study.

La Marra M, Messina A, Ilardi C, Staiano M, Di Maio G, Messina G Int J Environ Res Public Health. 2022; 19(18).

PMID: 36141782 PMC: 9517425. DOI: 10.3390/ijerph191811501.

References
1.
Gardner D, Murphy A, ODonnell H, Centorrino F, Baldessarini R . International consensus study of antipsychotic dosing. Am J Psychiatry. 2010; 167(6):686-93. DOI: 10.1176/appi.ajp.2009.09060802. View

2.
Ran M, Chan C, Chen E, Tang C, Lin F, Li L . Mortality of geriatric and younger patients with schizophrenia in the community. Suicide Life Threat Behav. 2008; 38(2):143-51. DOI: 10.1521/suli.2008.38.2.143. View

3.
Roy A . Family history of suicide. Arch Gen Psychiatry. 1983; 40(9):971-4. DOI: 10.1001/archpsyc.1983.01790080053007. View

4.
Tremeau F, Staner L, Duval F, Bailey P, Crocq M, Correa H . Suicidal behavior in schizophrenia and family history of suicide. Dialogues Clin Neurosci. 2011; 3(2):120-1. PMC: 3181650. View

5.
Innamorati M, Baratta S, Di Vittorio C, Lester D, Girardi P, Pompili M . Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic study. Schizophr Res Treatment. 2013; 2013:423205. PMC: 3563169. DOI: 10.1155/2013/423205. View